These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
449 related items for PubMed ID: 14690341
1. Atopic dermatitis is increased following vaccination for measles, mumps and rubella or measles infection. Olesen AB, Juul S, Thestrup-Pedersen K. Acta Derm Venereol; 2003; 83(6):445-50. PubMed ID: 14690341 [Abstract] [Full Text] [Related]
2. Measles, mumps and rubella infections and atopic disorders in MMR-unvaccinated and MMR-vaccinated children. Bernsen RM, van der Wouden JC. Pediatr Allergy Immunol; 2008 Sep; 19(6):544-51. PubMed ID: 18266826 [Abstract] [Full Text] [Related]
3. Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children. France EK, Glanz J, Xu S, Hambidge S, Yamasaki K, Black SB, Marcy M, Mullooly JP, Jackson LA, Nordin J, Belongia EA, Hohman K, Chen RT, Davis R, Vaccine Safety Datalink Team. Pediatrics; 2008 Mar; 121(3):e687-92. PubMed ID: 18310189 [Abstract] [Full Text] [Related]
4. Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations. Fombonne E, Zakarian R, Bennett A, Meng L, McLean-Heywood D. Pediatrics; 2006 Jul; 118(1):e139-50. PubMed ID: 16818529 [Abstract] [Full Text] [Related]
5. Lack of association between measles-mumps-rubella vaccination and autism in children: a case-control study. Mrozek-Budzyn D, Kiełtyka A, Majewska R. Pediatr Infect Dis J; 2010 May; 29(5):397-400. PubMed ID: 19952979 [Abstract] [Full Text] [Related]
6. Influence of MMR-vaccinations and diseases on atopic sensitization and allergic symptoms in Swiss schoolchildren. Roost HP, Gassner M, Grize L, Wüthrich B, Sennhauser FH, Varonier HS, Zimmermann H, Braun-Fahrländer Ch, SCARPOL-team. Pediatr Allergy Immunol; 2004 Oct; 15(5):401-7. PubMed ID: 15482514 [Abstract] [Full Text] [Related]
7. Why do parents hesitate to vaccinate their children against measles, mumps and rubella? Alfredsson R, Svensson E, Trollfors B, Borres MP. Acta Paediatr; 2004 Sep; 93(9):1232-7. PubMed ID: 15384890 [Abstract] [Full Text] [Related]
8. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age. Nolan T, Bernstein DI, Block SL, Hilty M, Keyserling HL, Marchant C, Marshall H, Richmond P, Yogev R, Cordova J, Cho I, Mendelman PM, LAIV Study Group. Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199 [Abstract] [Full Text] [Related]
9. Serosurvey of measles, mumps and rubella antibodies in Saudi children. Al-Mazrou YY, Khalil MK, Tischer A, Al-Jeffri MH, Al-Ghamdi YS, Bakhsh MM, Mishkas AA, Elgizouli SA. Saudi Med J; 2005 Oct; 26(10):1551-4. PubMed ID: 16228054 [Abstract] [Full Text] [Related]
10. Risk factors for atopic dermatitis in New Zealand children at 3.5 years of age. Purvis DJ, Thompson JM, Clark PM, Robinson E, Black PN, Wild CJ, Mitchell EA. Br J Dermatol; 2005 Apr; 152(4):742-9. PubMed ID: 15840107 [Abstract] [Full Text] [Related]
11. Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age. Redd SC, King GE, Heath JL, Forghani B, Bellini WJ, Markowitz LE. J Infect Dis; 2004 May 01; 189 Suppl 1():S116-22. PubMed ID: 15106100 [Abstract] [Full Text] [Related]
12. A serological survey of measles, mumps and rubella immunity among school aged children in Western Saudi Arabia. Jaber SM. Saudi Med J; 2006 Jan 01; 27(1):63-9. PubMed ID: 16432596 [Abstract] [Full Text] [Related]
13. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy. Sultana R, Rahman MM, Hassan Z, Hassan MS. Scand J Immunol; 2006 Dec 01; 64(6):684-9. PubMed ID: 17083626 [Abstract] [Full Text] [Related]
14. Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants. Spoulou V, Giannaki M, Vounatsou M, Bakoula C, Grafakos S. Bone Marrow Transplant; 2004 Jun 01; 33(12):1187-90. PubMed ID: 15077129 [Abstract] [Full Text] [Related]
15. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy. Zignol M, Peracchi M, Tridello G, Pillon M, Fregonese F, D'Elia R, Zanesco L, Cesaro S. Cancer; 2004 Aug 01; 101(3):635-41. PubMed ID: 15274078 [Abstract] [Full Text] [Related]
16. An epidemiological study on Japanese autism concerning routine childhood immunization history. Takahashi H, Suzumura S, Shirakizawa F, Wada N, Tanaka-Taya K, Arai S, Okabe N, Ichikawa H, Sato T. Jpn J Infect Dis; 2003 Jun 01; 56(3):114-7. PubMed ID: 12944678 [Abstract] [Full Text] [Related]
17. Allergic disease and sensitization in Steiner school children. Flöistrup H, Swartz J, Bergström A, Alm JS, Scheynius A, van Hage M, Waser M, Braun-Fahrländer C, Schram-Bijkerk D, Huber M, Zutavern A, von Mutius E, Ublagger E, Riedler J, Michaels KB, Pershagen G, Parsifal Study Group. J Allergy Clin Immunol; 2006 Jan 01; 117(1):59-66. PubMed ID: 16387585 [Abstract] [Full Text] [Related]
18. Response to measles, mumps, and rubella revaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy. Aurpibul L, Puthanakit T, Sirisanthana T, Sirisanthana V. Clin Infect Dis; 2007 Sep 01; 45(5):637-42. PubMed ID: 17683001 [Abstract] [Full Text] [Related]
19. Evaluation of potentially common adverse events associated with the first and second doses of measles-mumps-rubella vaccine. LeBaron CW, Bi D, Sullivan BJ, Beck C, Gargiullo P. Pediatrics; 2006 Oct 01; 118(4):1422-30. PubMed ID: 17015532 [Abstract] [Full Text] [Related]
20. Measles-mumps-rubella vaccination and asthma-like disease in early childhood. Hviid A, Melbye M. Am J Epidemiol; 2008 Dec 01; 168(11):1277-83. PubMed ID: 18845551 [Abstract] [Full Text] [Related] Page: [Next] [New Search]